Signum Life Science ApS: Financial statements 2024
CVR: 36559241
Source: annual report 2024, Danish Business Authority
01/01/2024 – 31/12/2024
Signum Life Science ApS (CVR 36559241) has filed annual accounts for 2024. In 2024, the company reported a gross profit of DKK -1,866,160 and a net result of DKK -5,936,982 compared with DKK -3,084,293 the year before. Equity in the 2024 report amounted to DKK 106,811,126. The solvency ratio was 85%. The company had 41 employees in the financial year.
- Gross Profit
- DKK -1,866,160
- Profit/Loss
- DKK -5,936,982
- Equity
- DKK 106,811,126
- Total Assets
- DKK 125,589,542
- Employees
- 41
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2024 | - | -1.9M | -5.9M | 106.8M | 41 |
| 2023 | - | 1.5M | -3.1M | 112.7M | 41 |
| 2022 | - | -184K | -11.3M | 115.8M | 36 |
| 2021 | - | 7.6M | 1.3M | 128.5M | 34 |
| 2020 | - | 8.1M | 1M | 128.2M | 32 |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2024
Signum Life Science ApS has published its annual report for 2023. Gross profit came to DKK 1,482,298, and the net result was DKK -3,084,293.
As of April 20, 2024, Søren Hvidsten Nielsen has joined the board of directors of Signum Life Science ApS.
As of April 20, 2024, Christian Bruun-Andersen has joined the board of directors of Signum Life Science ApS.
As of April 20, 2024, Felicia Nina Ida Salicath has joined the board of directors of Signum Life Science ApS.
As of April 20, 2024, Anne Marie Hedegaard Byskov has joined the board of directors of Signum Life Science ApS.
As of April 20, 2024, Anne Cathrine Falch-Jørgensen has joined the board of directors of Signum Life Science ApS.
As of April 20, 2024, Thomas Gross Nødvig has left the board of directors of Signum Life Science ApS.
As of April 20, 2024, Pia Krogsgaard Villadsen has left the board of directors of Signum Life Science ApS.
As of April 19, 2024, EY Godkendt Revisionspartnerselskab has been appointed auditor of Signum Life Science ApS.
As of April 19, 2024, PRICEWATERHOUSECOOPERS STATSAUTORISERET REVISIONSPARTNERSELSKAB has stepped down as auditor of Signum Life Science ApS.
About Signum Life Science ApS
Signum Life Science ApS is a Danish company of the type Anpartsselskab based in København Ø, founded in 2015. The company is registered under the industry Computerkonsulentbistand og forvaltning af computerfaciliteter. The company was previously named DLI Market Intelligence ApS. The management consists of Thomas Senderovitz. The board consists of Anja Cecilie Verhaug (chair), Mari-Ann Retz, Anne Marie Hedegaard Byskov and Søren Hvidsten Nielsen. The company is owned by DLI - DANSK LÆGEMIDDEL INFORMATION A/S and TJELLESEN MAX JENNE A/S. The company has 53 employees (2026). In 2025, the company reported a gross profit of DKK -67,441,461 and a net result of DKK -66,049,966 compared with DKK -5,936,982 the year before. Equity in the 2025 report amounted to DKK 40,680,589.
